article thumbnail

US frets over pharma supply chain security

pharmaphorum

The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic medicine, as well as medical supplies, antibiotics and ingredients required to manufacture treatments. By its own figures, the agency managed 61% of the planned inspections it had scheduled for 2020.

article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

The race to produce a vaccine which could protect the world against COVID-19 brought the topic of diversity in clinical trials, or lack of it, into sharp focus. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy. The pandemic brought imbalances into sharp focus.

Packaging 143